{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:16:28Z","timestamp":1766747788177,"version":"3.48.0"},"reference-count":27,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003153","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:18:21Z","timestamp":1069366701000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["D-cycloserine for Alzheimer's disease"],"prefix":"10.1002","volume":"2010","author":[{"given":"Roy","family":"Jones","sequence":"first","affiliation":[{"name":"St. Martin's Hospital; Research Institute for the Care of the Elderly; Bath UK BA2 5RP"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Laake","sequence":"additional","affiliation":[{"name":"Deceased; Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Rita","family":"\u00d8kseng\u00e5rd","sequence":"additional","affiliation":[{"name":"Karolikika University Hospital; Department of Geriatric Medicine, Neurogeriatrics; Huddilye 141 86 Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,22]]},"reference":[{"key":"10.1002\/14651858.CD003153-BIB0001|cit1","unstructured":"Pauvlik JM Searle clinical research report. A two year, multicenter, randomized, double-blind controlled parallel group study of cycloserine in the treatment of Alzheimer's disease with six months placebo control Report No. EC6-93-06-025, July 30, 1993. Skokie, IL: GD Searle, 1993 1993"},{"issue":"4","key":"10.1002\/14651858.CD003153-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/089198879500800405","article-title":"Evaluation of cycloserine in the treatment of Alzheimer's disease","volume":"8","author":"Fakouhi","year":"1995","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003153-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00002826-199502000-00004","article-title":"Cognitive and quantified electroencephalographic correlates of cycloserine treatment in Alzheimer's disease","volume":"18","author":"Mohr","year":"1995","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD003153-BIB0004|cit4","unstructured":"Pauvlik JM Searle clinical research report. A two year, multicenter, randomized, double-blind controlled parallel group study of cycloserine in the treatment of Alzheimer's disease with six months placebo control Report No. NC6-93-06-009, September 29, 1993. Skokie, IL: GD Searle, 1993 1993"},{"issue":"2","key":"10.1002\/14651858.CD003153-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1212\/WNL.46.2.420","article-title":"d-Cycloserine enhances implicit memory in Alzheimer patients","volume":"46","author":"Schwartz","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003153-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/jnp.10.2.224","article-title":"A preliminary study of D-cycloserine treatment in Alzheimer's disease","volume":"10","author":"Tsai","year":"1998","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"3","key":"10.1002\/14651858.CD003153-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1176\/ajp.156.3.467","article-title":"Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.","volume":"156","author":"Tsai","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003153-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00002093-199408030-00006","article-title":"D-cycloserine treatment of Alzheimer disease","volume":"8","author":"Randolph","year":"1994","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1002\/14651858.CD003153-BIB0009|cit9","volume-title":"Diagnostic and statistical manual of mental disorders","volume":"III revised","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD003153-BIB0010|cit10","volume-title":"Diagnostic and statistical manual of mental disorders","volume":"IV","author":"American Psychiatric Association","year":"1994"},{"issue":"6553","key":"10.1002\/14651858.CD003153-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/378182a0","article-title":"Distinct components of spatial learning revealed by prior training and NMDA receptor blockade","volume":"378","author":"Bannerman","year":"1995","journal-title":"Nature"},{"issue":"4","key":"10.1002\/14651858.CD003153-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001191","article-title":"Rivastigmine for Alzheimer's disease","author":"Birks","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003153-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001190.pub2","article-title":"Donepezil for dementia due to Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003153-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(91)91668-Q","article-title":"D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain.","volume":"565","author":"Chessell","year":"1991","journal-title":"Brain Research"},{"issue":"2","key":"10.1002\/14651858.CD003153-BIB0015|cit15","article-title":"Cochrane Reviewer's Handbook 4.2.0 [updated March 2003]","author":"Clarke","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD003153-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\": a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD003153-BIB0017|cit17","first-page":"218","article-title":"ECDEU Assessment Manual for Psychopharmacology","volume":"2","author":"Guy","year":"1976","journal-title":"US Dept Health, Education and Welfare Publication (ADM) 76-338"},{"key":"10.1002\/14651858.CD003153-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1749-6632.1991.tb00226.x","article-title":"Effects of NMDA modulation in scopolamine dementia","volume":"640","author":"Jones","year":"1991","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"12","key":"10.1002\/14651858.CD003153-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1212\/WNL.44.12.2315","article-title":"The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease","volume":"44","author":"Knopman","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003153-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1212\/WNL.52.1.78","article-title":"Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses","volume":"52","author":"Launer","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003153-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of health and human services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003153-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0304-3940(89)90441-2","article-title":"Loss of glycine-dependent radioligand binding to the N-methyl-D-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease","volume":"101","author":"Procter","year":"1989","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD003153-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD003153-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1532-5415.2000.tb02634.x","article-title":"Memory complaint in a community sample aged 70 and older","volume":"48","author":"Turvey","year":"2000","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003153-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/026988119200600135","article-title":"The cognitive drug research computerized assessment systems for elderly, AAMI and demented patients","volume":"6","author":"Wesnes","year":"1992","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD003153-BIB0026|cit26","article-title":"ICD-10. Tenth revision of the International Classification of Diseases. Chapter V (F): Mental and Behavioural disorders (including psychological development). Clinical descriptions and diagnostic guidelines","author":"World Health Organisation (WHO)","year":"1991","journal-title":"Mental and behavioural disorders. Clinical descriptions and diagnostic guidelines"},{"issue":"2","key":"10.1002\/14651858.CD003153-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003153","article-title":"D-cycloserine for Alzheimer's disease","author":"Jones","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T08:47:42Z","timestamp":1766738862000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003153"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2002,4,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003153","relation":{},"ISSN":["1465-1858"],"issn-type":[{"type":"electronic","value":"1465-1858"}],"subject":[],"published":{"date-parts":[[2002,4,22]]}}}